STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2341 by analyst upside · 2026-08-13
WRBY
Warby Parker Inc.
Healthcare · Market Cap $3B · P/E 422.0x
ANALYST PRICE TARGET
+20.3%
implied upside to consensus target
Current Price $25.32
Consensus Target $30.46
Bull Target $35.0
Bear Target $24.0
Analysts Covering 13
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
7
Hold
4
Sell
0
52-Week Low $14.96
52-Week High $31.0
YTD Return +11.9%
FUNDAMENTALS
Market Cap $3B
P/E Ratio (TTM) 422.0x
Forward P/E 42.8x
EPS (TTM) $0.06
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $912M
Profit Margin 0.8%
52-WEEK RANGE
52-Week Low $14.96
52-Week High $31.0
Current Price $25.32
Bear Target $24.0
Bull Target $35.0
● Now $25.32 ● Target $30.46
TRADING DATA
Avg Volume 3.2M
YTD Return +11.9%
Analyst Count 13
Consensus Buy
Upside to Target +20.3%
Last Updated 2026-08-13

ANALYST SUMMARY

Warby Parker Inc. (WRBY) is currently trading at $25.32 with a Wall Street consensus price target of $30.46, implying potential upside of 20.3% over the next 12 months. 13 analysts currently cover WRBY, with a consensus rating of Buy - 69% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $35.0, while the most cautious has a target of $24.0.

WRBY operates in the Healthcare sector with a market capitalisation of $3B. The stock is up 11.9% year-to-date and is currently trading near the upper end of its 52-week range of $14.96 – $31.0.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for WRBY, with each firm's 90-day track record across all stocks we track. See full firm rankings →

UBS - Reiterated
Neutral → Neutral 2026-05-08 33% win rate (6 calls)
BTIG - Reiterated
Buy → Buy 2026-05-07 38% win rate (8 calls)
Citigroup - Reiterated
Neutral → Neutral 2026-03-17 Building track record
Telsey Advisory Group - Reiterated
Outperform → Outperform 2026-02-20 Building track record
Telsey Advisory Group - Reiterated
Outperform → Outperform 2026-02-10 Building track record
Piper Sandler - Reiterated
Overweight → Overweight 2025-12-16 14% win rate (7 calls)
Stifel - Reiterated
Hold → Hold 2025-12-12 Building track record
BTIG - Reiterated
Buy → Buy 2025-12-11 38% win rate (8 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
55
out of 100
Coverage depth
20/30
Consensus clarity
21/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →